09/10/2026
By 2050, half the world’s population will be affected by myopia …
Since its foundation, Biotech has been determined to create and develop a phakic lens to address myopia, as myopia is affecting more and more people and the market was highly demanding of more phakic IOL options.
EYECRYL® Phakic IOL is the result of determination, innovation, excellence, and the love we have for what we do.
We are proud today that the EYECRYL® Phakic IOL range is available in more than 44 countries, with more than 300.000 lenses implanted worldwide, enhancing people’s vision and lives.
To know more about Eyecryl Phakic, visit:
https://biotechhealthcare.com/phakic-lenses/
https://unleashtheindependence.com/